About Kerastem

Kerastem is a private company dedicated to driving innovative hair loss therapies to market


Kerastem is focused on the development of product solutions for women and men with early hair loss. The company’s core technology focuses on the emerging relationship between adipose (fat) tissue and hair, highlighting the increasingly important role that adipose plays in driving the hair growth cycle.*


*Experimental Dermatology, 2012, 21, 827–830


biminiKerastem is a Bimini Technologies’ company. Bimini is a private holding company focused on the aesthetic, cash-pay marketplace. The company seeks market approved or high-potential performing assets that complement or expand the existing product portfolio.

Today, the Bimini group of companies includes Puregraft and Kerastem. Puregraft is the world’s market leader in the commercialization of innovative fat transfer tools. Today, Puregraft’s products are distributed in over 60 countries worldwide.

Kerastem is a wholly owned subsidiary of Bimini Technologies.  In the United States, Kerastem has a focused US FDA Clinical Trial Strategy to enable driving hair growth therapies to market.  Kerastem’s solution for female and male pattern baldness is currently in a phase II clinical trial.  Kerastem is in parallel actively engaged in market development activities in Europe and Japan.


Bradford A. Conlan Chief Executive Officer

Mr. Conlan is the founder and CEO of Bimini Technologies. Mr. Conlan ...

Eric J. Daniels MD, MBA Chief Medical Officer

Dr. Eric Daniels currently serves as the Chief Medical Officer of ...

Richard A. Heise, Jr.

Mr. Heise is a veteran entrepreneur having been involved in founding or ...

James F. Conlan

Mr. Conlan is Co-Chairman of Sidley Austin’s firm- wide Corporate ...

John J. Gasparovic

Mr. Gasparovic is the Vice president, General Counsel and Secretary of ...

Larry Nyhan

Mr. Nyhan is Co-Chairman of the Sidley Austin’s firm-wide Corporate ...